These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 1353716)

  • 21. Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review.
    Pappa S; Dazzan P
    Psychol Med; 2009 Jul; 39(7):1065-76. PubMed ID: 19000340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low plasma iron status and akathisia.
    Barton A; Bowie J; Ebmeier K
    J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):671-4. PubMed ID: 1976763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal involuntary movements in patients on long-acting neuroleptics.
    Oyewumi LK; Lapierre YD; Gray R; Batth S; Gelfand R
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):719-23. PubMed ID: 6141614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placebo response in refractory tardive akathisia.
    Remington G; Fornazzari L; Sethna R
    Can J Psychiatry; 1993 May; 38(4):248-50. PubMed ID: 8100184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia.
    Gebhardt S; Härtling F; Hanke M; Theisen FM; von Georgi R; Grant P; Mittendorf M; Martin M; Fleischhaker C; Schulz E; Remschmidt H
    Eur Child Adolesc Psychiatry; 2008 Feb; 17(1):44-53. PubMed ID: 17876506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises.
    Sachdev P; Tang WM
    Aust N Z J Psychiatry; 1992 Dec; 26(4):666-70. PubMed ID: 1362053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population.
    Cohen S; Khan A; Zheng Y; Chiles J
    Acta Psychiatr Scand; 1991 Mar; 83(3):234-7. PubMed ID: 1674398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of betaxolol in neuroleptic-induced akathisia.
    Adler LA; Angrist B; Rotrosen J
    Psychiatry Res; 1991 Nov; 39(2):193-8. PubMed ID: 1686812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of tardive akathisia with clonidine.
    Nishikawa T; Koga I; Uchida Y; Tanaka M
    Kurume Med J; 1990; 37(3):185-7. PubMed ID: 1980934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine-induced tardive dyskinesia and hypothyroidism.
    Mendhekar DN; Duggal HS
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):245-6. PubMed ID: 16720805
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuroleptic-associated tardive syndromes.
    Jeste DV; Wisniewski AA; Wyatt RJ
    Psychiatr Clin North Am; 1986 Mar; 9(1):183-92. PubMed ID: 2870479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A placebo-controlled trial of selegiline (L-deprenyl) in the treatment of tardive dyskinesia.
    Goff DC; Renshaw PF; Sarid-Segal O; Dreyfuss DA; Amico ET; Ciraulo DA
    Biol Psychiatry; 1993 May; 33(10):700-6. PubMed ID: 8102552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of topography on the cognitive and psychopathological effects of tardive dyskinesia.
    Brown KW; White T
    Am J Psychiatry; 1992 Oct; 149(10):1385-9. PubMed ID: 1356314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia.
    Sundram S; Lambert T; Piskulic D
    Acta Psychiatr Scand; 2008 Jun; 117(6):474-8. PubMed ID: 18479320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of clozapine on treatment-resistant akathisia and concomitant tardive dyskinesia.
    Wirshing WC; Phelan CK; van Putten T; Marder SR; Engel J
    J Clin Psychopharmacol; 1990 Oct; 10(5):371-3. PubMed ID: 1979566
    [No Abstract]   [Full Text] [Related]  

  • 37. Race and tardive dyskinesia among outpatients at a CMHC.
    Glazer WM; Morgenstern H; Doucette J
    Hosp Community Psychiatry; 1994 Jan; 45(1):38-42. PubMed ID: 7907310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Withdrawal symptoms after long-term treatment with low-potency neuroleptics.
    Chouinard G; Bradwejn J; Annable L; Jones BD; Ross-Chouinard A
    J Clin Psychiatry; 1984 Dec; 45(12):500-2. PubMed ID: 6150030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tardive akathisia and tardive dyskinesia].
    Fennig S; Helben J; Neumann M
    Harefuah; 1991 Jan; 120(2):71-2. PubMed ID: 1672523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum creatine phosphokinase elevations in patients with tardive dyskinesia.
    Egan MF; Dargham AA; Kirch DG; Wyatt RJ
    Br J Psychiatry; 1993 Apr; 162():551-3. PubMed ID: 8097656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.